These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29388721)

  • 1. World bleeding disorders registry: The pilot study.
    Coffin D; Herr C; O'Hara J; Diop S; Hollingsworth R; Srivastava A; Lillicrap D; van den Berg HM; Iorio A; Pierce GF
    Haemophilia; 2018 May; 24(3):e113-e116. PubMed ID: 29388721
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct transfer of data of people with haemophilia from the Thai Haemophilia Treatment Centre Registry to the World Bleeding Disorders Registry of the World Federation of Hemophilia.
    Chuansumrit A; Youttananukorn W; Sirachainan N; Natesirinilkul R; Ruchutrakool T
    Haemophilia; 2022 Mar; 28(2):e68-e70. PubMed ID: 35037355
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemophilia centre twinning with Nanfang Hospital, Guangzhou, China. Challenges and opportunities.
    Luke KH
    Transfus Apher Sci; 2001 Oct; 25(2):83-7. PubMed ID: 11761278
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct data transfer of people with hereditary bleeding disorders from the Thai haemophilia treatment centre registry to the Annual Global Survey of the World Federation of Hemophilia.
    Chuansumrit A; Youttananukorn W; Sirachainan N; Natesirinilkul R; Ruchutrakool T
    Haemophilia; 2024 Jan; 30(1):245-248. PubMed ID: 37932878
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancing haemophilia care through registries.
    Dolan G; Makris M; Bolton-Maggs PH; Rowell JA
    Haemophilia; 2014 May; 20 Suppl 4():121-9. PubMed ID: 24762287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary bleeding disorders in Kenya.
    Kitonyi GW; Kasili EG
    East Afr Med J; 1981 Oct; 58(10):738-47. PubMed ID: 7343310
    [No Abstract]   [Full Text] [Related]  

  • 7. Demographics of hemophilia in developing countries.
    Evatt BL
    Semin Thromb Hemost; 2005 Nov; 31(5):489-94. PubMed ID: 16276455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements.
    Skinner MW
    Br J Haematol; 2011 Sep; 154(6):704-14. PubMed ID: 21707577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and surveillance of the hemophiliacs at the National Institute of Hematology and Blood Transfusion of Vietnam.
    Bach QT; Colab
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():113-5. PubMed ID: 7886550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancement in the treatment of haemophilia.
    Bhardwaj R; Rath G; Goyal AK
    Int J Biol Macromol; 2018 Oct; 118(Pt A):289-295. PubMed ID: 29928908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of haemophilia treatment in Serbia: National Haemophilia Registry Report.
    Miković D; Rakić L; Janković-Trsnjak G; Baklaja R; Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():23-7. PubMed ID: 20229678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-year study of adolescent boys suffering from haemophilia and allied disorders.
    Rainsford SG; Hall A
    Br J Haematol; 1973 May; 24(5):539-51. PubMed ID: 4541300
    [No Abstract]   [Full Text] [Related]  

  • 13. Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre.
    Jayakar JP; O'Neill N; Yan M; Nisenbaum R; Garvey MB; Teitel J; Sholzberg M
    Haemophilia; 2018 Sep; 24(5):e383-e387. PubMed ID: 30112783
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemophilia in the 1990s: principles of management and improved access to care.
    Kasper CK; Mannucci PM; Bulyzhenkov V; Brettler DB; Chuansumrit A; Heijnen L; Isarankura P; Kernoff PB; Peake I; Rickard KA
    Semin Thromb Hemost; 1992 Jan; 18(1):1-10. PubMed ID: 1574710
    [No Abstract]   [Full Text] [Related]  

  • 15. Making haemophilia a global priority.
    Lancet; 2012 Apr; 379(9824):1366. PubMed ID: 22500863
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations from Global Survey 2001: an emerging database for progress.
    Evatt BL
    Haemophilia; 2002 Mar; 8(2):153-6. PubMed ID: 11952853
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study.
    Shapiro AD; Donfield SM; Lynn HS; Cool VA; Stehbens JA; Hunsberger SL; Tonetta S; Gomperts ED;
    Pediatrics; 2001 Dec; 108(6):E105. PubMed ID: 11731632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there systemic comorbidities in haemophilia unrelated to bleeding and transfusion-transmitted infections?
    Janczar S; Wegner O; Kostrzewska M; Stolarska M; Paige AJ; Mlynarski W
    Haemophilia; 2015 Jan; 21(1):e83-5. PubMed ID: 25296954
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of acute bleeding on daily activities of patients with congenital hemophilia with inhibitors and their caregivers and families: observations from the Dosing Observational Study in Hemophilia (DOSE).
    Recht M; Neufeld EJ; Sharma VR; Solem CT; Pickard AS; Gut RZ; Cooper DL
    Value Health; 2014 Sep; 17(6):744-8. PubMed ID: 25236999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.
    Mariani G; Scheibel E; Nogao T; Kasper CK; Ewing NP; Mauser-Bunschoten E; Ghirardini A; Bellocco R; Brackman HH
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):62-4. PubMed ID: 7939781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.